CLOSER VASCULAR SEALING SYSTEM

Device, Hemostasis, Vascular

FDA Premarket Approval P150022

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for the closer vascular sealing system (vss). This device is indicated for the percutaneous closure of femoral artery access sites while reducing times to hemostasis and ambulation as compared to performance goals in patients who have undergone diagnostic or interventional endovascular procedures utilizing 5, 6 and 7 fr procedural sheaths.

DeviceCLOSER VASCULAR SEALING SYSTEM
Classification NameDevice, Hemostasis, Vascular
Generic NameDevice, Hemostasis, Vascular
ApplicantREX MEDICAL, L.P.
Date Received2015-06-25
Decision Date2016-02-12
Notice Date2016-03-03
PMAP150022
SupplementS
Product CodeMGB
Docket Number16M-0805
Advisory CommitteeCardiovascular
Expedited ReviewNo
Combination Product No
Applicant Address REX MEDICAL, L.P. 555 E. North Lane Suite 5035 conshohocken, PA 19428
Summary:Summary of Safety and Effectiveness
Labeling: Labeling
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P150022Original Filing
S007 2018-09-11 30-day Notice
S006
S005 2018-05-21 Real-time Process
S004 2018-01-08 Special (immediate Track)
S003 2017-11-02 Real-time Process
S002 2016-08-15 Real-time Process
S001 2016-03-15 Real-time Process

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.